Skip to main content
  • 13 Accesses

Abstract

Clinical as well as experimental studies have found an interindividual variability in the immunosuppressive effect of cyclosporine (CsA). In renal transplant patients treated with CsA and prednisolone alone, biopsy-verified rejections were significantly more frequent in DRw6-positive than in DRw6-negative graft recipients. The relative risk for developing a graft rejection independently of the CsA blood levels increased in HLA-DRw6-positive transplant patients. Although no statistical significance of the CsA levels within different DR phenotypes could be assessed, HLA-DR2-positive graft recipients with biopsy-verified rejection episodes had significantly lower CsA levels than DR2-negative patients (P = 0.01). Our results would indicate a very low CsA sensitivity of HLA-DRw6-positive graft recipients and might explain previous results describing an increased incidence of rejection and decreased graft survival rates in these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Cook D (1986) HLA-DR associated immune responsiveness. In: Terasaki P (ed) Clinical transplants. UCLA Tissue Typing Laboratory, Los Angeles, pp 247–256

    Google Scholar 

  2. Ferguson R, Canafax D, Sawchuck R, Simmons R (1986) Cyclosporin blood level monitoring: the early posttransplant period. Transplant Proc 28 (2) [Suppl 1]: 113–116

    Google Scholar 

  3. Hamilton G, Roth E, Wallisch E, Tichy F (1985) Semi-automated high performance liquid chromatographic determination of cyclosporin A in whole blood using one-step sample purification and column-switching. J Chromatogr 341:411–419

    PubMed  CAS  Google Scholar 

  4. Hendriks G, Schreuder G, Claas F, D’Amaro J, Persijn G, Cohen B, van Rood J (1983) HLA-DRw6 and renal allograft rejection. BMJ 286:85–87

    Article  PubMed  CAS  Google Scholar 

  5. Hoitsma A, van Lier H, Reekers P, Koene R (1985) Treatment of acute rejection of cadaveric renal allografts with rabbit antithymocyte globulin: influence of blood transfusion and DRw6. Transplant Proc 1:72–74

    Google Scholar 

  6. Kahan BD (1985) Individualization of cyclosporine therapy using pharmacokinetic and pharmacodynamic parameters. Transplantation 40:457–476

    Article  PubMed  CAS  Google Scholar 

  7. Kahan BD, Grevel J (1988) Optimization of cyclosporine therapy in renal transplantation by a pharmacokinetic strategy. Transplantation 46:631–644

    Article  PubMed  CAS  Google Scholar 

  8. Kasiske L, Hein-Duthoy K, Rao V, Awin M (1988) The relationship between cyclosporine pharmacokinetic parameters and subsequent acute rejection in renal transplant recipients. Transplantation 46:716–722

    Article  PubMed  CAS  Google Scholar 

  9. Persijn G, D’Amaro G, De Lange P, Schreuder T, Thorogood J, Zantvoort F, Rood J van (1989) The effect of mismatching and sharing of HLA, B and DR antigens on kidney graft survival in eurotransplant 1982 to 1988. In: Terasaki (ed) Clinical transplant, UCLA Tissue Typing Laboratory, Los Angeles, p 237

    Google Scholar 

  10. Povlsen J, Rasmussen A, Madsen M, Lamm L (1990) Ciclosporine-induced immunosuppression in-vitro. Scand J Immunol 32:45–51

    Article  PubMed  CAS  Google Scholar 

  11. Scorza R, Vanoli M Cigognini A, Fabio G, De Bernardi B, Zanussi C (1988) In vitro effects of cyclosporine A on allogenic and autologous lymphocyte stimulation: influence of HLA phenotypes. Transplant Proc 20 [Suppl 2]: 122–124

    PubMed  CAS  Google Scholar 

  12. Zlabinger G, Pohanka E, Hajek-Rosenmayer A, Pavlicek E, Watschinger B, Traindl O, Kovarik J (1990) Influence of HLA pehnotypes on the inhibition of in vitro alloreactivity by cyclosporin A. Transplantation 50:1038–1042

    Article  PubMed  CAS  Google Scholar 

  13. Zlabinger G, Ulrich W, Pecherstorfer M, Watschinger B, Traindl O, Meron G, Pohanka E, Wolfram J, Kovarik J (1989) Clinical experience with OKT3 monoclonal antibody for treatment of acute renal allograft rejection based on sequential histological evaluation. Clin Transplant 3:215–222

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Kudlacek, S., Zlabinger, G.J., Pohanka, E., Hamilton, G., Rosenmayr, A., Kovarik, J. (1992). Insensitivity to cyclosporine may explain the HLA-DRw6 recipient effect. In: Kootstra, G., Opelz, G., Buurman, W.A., van Hooff, J.P., MacMaster, P., Wallwork, J. (eds) Transplant International Official Journal of the European Society for Organ Transplantation. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77423-2_163

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-77423-2_163

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-55342-7

  • Online ISBN: 978-3-642-77423-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics